Daily Health News Issue # 480 for 4/23/2026
- We had a lot of queries about yesterday's item related to the analysis of Managed Medicaid proposals across mutliple states.
- We are trying to see if additional data is available.
- We also are including a 'top item' so you can get the actual analysis.
- Dept of War Hegseth has made flu vaccinations no longer mandatory for military personnel. These had been in place since the '50s.
- The NASA item is pretty intense – organs shipped to your door by drone.
- The "$440K" breast reduction bill – is about the larger practice of some vendors capitalizing on claim arbitration policies brought about thru the No Surprises Act.
- A study purports to demonstrate that youth suicides have declined since the introduction of the "988 hotline"
- The ways that folks can get/afford GLP-1 drugs continues to increase:
- Amazon will be supporting GLP-1s via convenient online
- HHS will continue to make available under Medicare
See our "top articles" list below. For a synoposis of all 56 articles curated today, see further below, and to see each of these articles listed with short summary just click here.
Click here to keep those cards and letters coming… including if you want to – gasp! – unsubscribe (please don't!)
Audio/Video
Today's Quote:
“‘Wealth was an inferior object; but what glory would attend the discovery, if I could banish disease from the human frame and render man invulnerable to any but a violent death!’ … – Mary Shelley, Frankenstein; or, The Modern Prometheus, 1818”
Today's Top Articles
Of the 56 articles curated today, here are the top 11 in our judgment:
| Article_Title | Article_Takeaway |
|---|---|
| Flu vaccine no longer mandated for U.S. troops, defense secretary says | Defense Secretary Pete Hegseth ended the military-wide flu shot mandate, citing medical autonomy and religious freedom while allowing service branches to request exemptions. |
| Trump admin shifts course on Medicare GLP-1 coverage | The Trump administration is delaying a Medicare GLP-1 coverage pilot after insurer pushback, while launching a temporary program that keeps patient access but shifts costs to CMS. |
| NASA to test drone delivery of donor organs | NASA and UNOS are studying whether drones can make organ transport faster, cheaper, and more reliable while keeping donor tissue viable. |
| Steak n Shake goes full MAHA | Steak n Shake named a MAHA officer, signaling how RFK Jr.’s health movement is reshaping even fast-food corporate strategy. |
| Oz unveils nationwide plan to tackle Medicaid fraud at POLITICO Summit | CMS Administrator Mehmet Oz announced a nationwide anti-fraud push requiring all states to submit Medicaid provider revalidation plans within 30 days. |
| Amazon.com Launches Program for GLP-1 Weight-Loss Drugs With One Medical | Amazon is rolling out a One Medical GLP-1 weight-loss program with clear pricing and ongoing clinical supervision, pressuring rivals in the booming obesity-drug market. |
| Youth Suicides Declined After Creation of National Hotline | A new study links the 988 hotline rollout to a measurable decline in youth suicides, especially in states with more answered calls. |
| Pace of N.I.H. Funding Slows Further in Trump’s Second Year | NIH grantmaking has slowed sharply under Trump, with staffing losses and ideological screening delaying thousands of research projects and risking unused congressional funds. |
| A $440,000 Breast Reduction: How Doctors Cashed In on a Consumer Protection Law | A surprise-billing law shielded patients, but doctors and arbitration firms exploited it to win outsized payments and drive up health costs. |
| Medicare Delays Full Obesity-Drug Program Rollout After Insurers Push Back | CMS will extend its interim obesity-drug coverage program to 2027 after major insurers balked at a longer-term model. |
| Medicaid Managed Care Procurement Reveals Systematic Overemphasis of Technology and Equity Performance Claims Across 32 States | Medicaid managed care organizations overemphasize technology and health equity claims in procurement documents while underemphasizing core care delivery areas like chronic disease management and workforce capacity. |
Today's Graphic
Mental health and substance abuse disorder spending by year from 2000 to 2021 (Source: Health Affairs March 2026). See below or click here

Today's Digest
Here is a summary of all 56 articles curated today into the Competitive Research Analytics Platform for 4/23/2026:
Today's briefing reflects a healthcare landscape caught between technological ambition and institutional strain. GLP-1 therapeutics dominated multiple storylines: CMS extended its interim obesity-drug coverage program through 2027 after major insurers balked at a longer-term pilot, leaving Medicare to absorb costs directly. Amazon meanwhile launched a structured One Medical GLP-1 program with transparent pricing and clinical supervision, intensifying competitive pressure on telehealth weight-loss rivals — including Mochi Health, which faces both an Eli Lilly trademark lawsuit over compounded tirzepatide and a California class action over provider misclassification.
On the fraud front, CMS Administrator Mehmet Oz ordered all 50 states to submit Medicaid provider revalidation plans within 30 days, while a Trump-aligned think tank escalated calls for site-neutral payments, 340B reform, and tighter hospital tax scrutiny.
Elevance Health beat Q1 earnings expectations despite lingering Medicaid and CMS sanction risks; UnitedHealth's Optum similarly outperformed while announcing a $1.5 billion AI investment.
NIH grantmaking has slowed sharply under Trump, with ideological screening and staffing losses threatening thousands of research projects. Behavioral health EHR adoption remains high but interoperability lags. Nurse turnover climbed to 17.6%, costing hospitals roughly $5.19 million annually. A new study linked the 988 Lifeline rollout to measurable youth suicide declines. Oklahoma advanced a Medicaid expansion ballot measure. Health Net committed $10 million toward LA affordable housing. NASA and UNOS are exploring drone-based organ transport. The FDA is increasingly embracing real-world evidence in drug development.
See back issues of Daily C.R.A.P. on our website right here in the archive.
As of today, C.R.A.P. now has 204 subscribers
Want to drop us a line? E-Mail Us
Click here for ALL articles added to C.R.A.P. in the past 24 hours